Profile

NIKIFOROS BALLIAN

GENERAL SURGEON

  1. General
  • Education & Academic Titles
    • Graduate of St. Bartholomew’s & The Royal London School of Medicine, university of London
    • Surgery resident at Johns Hopkins Hospital and The University of Wisconsin Hospital
    • Esophageal surgery fellow, University of Pittsburgh Medical Center
  • Professional Experience
    • Private Practice General Surgeon, Athens, Greece, 2013 - today
  • Clinical Interest
    • General and Upper Gastrointestinal tract Surgery
  • Awards & Distinctions
    • Best oral presentation by a resident Ballian N, Schuchert MJ, McCormick KN, Ferson PF, Abbas G, Awais O, Weksler B, Christie NA, Luketich JD, Landreneau RJ. Bronchoplasty in the Management of Hilar Neoplasms: Ten Year Experience. Eastern Cardiothoracic Surgical Society 50th Annual Meeting, October 4-6, Naples, FL
  • Recent Publications
    1. Ballian N, Luketich JD, Shende M, Levy RM, Awais O, Winger D, Jobe BA, Weksler B, Schuchert MJ, Landreneau RJ, Nason KS. A clinical prediction rule for morbidity and mortality after giant paraesophageal hernia repair. J Thorac Cardiovasc Surg 2013;145:721-9.
    2. Ballian N, Wan Y, Rajamanickam V, Harms BA, Foley EF, Heise CP, Greenberg CC, Kennedy GD. Predictors of mortality after emergent surgery for acute colonic diverticulitis: analysis of National Surgical Quality Improvement Project data. J Trauma Acute Care Surg 2013;74:611-16.
    3. Ballian N, Weisensel N, Wan Y, Rajamanickam V, Foley EF, Heise CP, Harms BA, Kennedy GD. Comparable postoperative morbidity and mortality after laparoscopic and open emergent colon resection: outcomes from the ACS NSQIP. World J Surg. 2012; 36:2488-96.
    4. Ballian N, Lubner MG, Munoz A, Harms B, Heise CP, Foley EF, Kennedy GD. Visceral obesity predicts outcomes of total mesorectal excision for rectal adenocarcinoma. J Surg Oncol. 2012;105:365-70.
    5. Liu SH, Smyth-Templeton N, Davis AR, Davis EA, Ballian N, Li M, Liu H, Fisher W, Brunicardi FC. Multiple treatment cycles of liposome-encapsulated adenoviral RIP-TK gene therapy effectively ablate human pancreatic cancer cells in SCID mice. Surgery. 2011; 149:484-95. 6. Alexandraki KI, Griniatsos J, Bramis KI, Ballian N, Dimitriou N, Giannakakis T, Tsigris C, Felekouras E, Kaltsas GA. Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria. J Endocrinol Invest. 2011; 34:255-9.
    6. Ballian N, Androulakis II, Chatzistefanou K, Samara C, Tsiveriotis K, Kaltsas GA. Optic neuropathy following radiotherapy for Cushing's disease: case report and literature review. Hormones (Athens). 2010; 9:269-73.
    7. Ballian N, Rabiee R, Andersen DK, Elahi D, Gibson BR. Glucose metabolism in burn patients: the role of insulin and other endocrine hormones. Burns 2010; 36:599-605.
    8. Ballian N, Yamane B, Leverson G, Harms B, Heise CP, Foley EF, Kennedy GD. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma. Ann Surg Oncol 2010; 17:1606-13.
    9. Ballian N, Zarebczan B, Munoz A, Harms B, Heise CP, Foley EF, Kennedy GD. Routine evaluation of the distal colon remnant before Hartmann’s reversal is not necessary in asymptomatic patients. J Gastrointest Surg. 2009; 13:2260-2267.
    10. Ballian N, Loeffler AG, Rajamanickam V, Norstedt PA, Weber SM, Cho CS. A simplified prognostic system for resected pancreatic neuroendocrine neoplasms. HPB (Oxford) 2009; 11:422-8.
    11. Ballian N, Adler JT, Sippel RS, Chen H. Revisiting mass size as an indication for adrenalectomy. J Surg Res. 2009; 156:16-20.
    12. Ballian N, Mahvi DM, Kennedy GD. Colonoscopic findings and tumor site do not predict bowel obstruction during medical treatment of stage IV colorectal cancer. Oncologist 2009; 14:580-5.
    13. Ballian N, Liu S, Brunicardi FC. Transcription factor pancreatic duodenal homeobox-1 in human colonic adenocarcinoma: Potential for use as a tumor marker? World J Gastroenterol. 2008; 14:5823-6.
    14. Liu S, Ballian N, Belaguli NS, Patel S, Templeton NS, Fisher W, Brunicardi FC. PDX-1 is a potential molecular target for the treatment of human pancreatic cancer. Pancreas. 2008; 37:210-220.
    15. Ballian N, Chrisoulidou A, Nomikos P, Samara C, Kontogeorgos G, Kaltsas GA. Hypophysitis superimposed on a non-functioning pituitary adenoma: diagnostic clinical, endocrine and radiologic features. J Endocrinol Invest. 2007; 30:677-83.
    16. Ballian N, Brunicardi FC. Proliferation, hyperplasia, neogenesis and neoplasia in the islets of Langerhans. Pancreas. 2007; 35:199-206.
    17. Feanny MA, Fagan SP, Ballian N, Liu SH, Li Z, Wang X, Fisher W, Brunicardi FC, Belaguli NS. PDX-1 Expression Is Associated with Islet Proliferation In Vitro and In Vivo. J Surg Res. 2008; 144:8-16.
    18. Liu SH, Davis A, Li Z, Ballian N, Davis E, Wang XP, Fisher W, Brunicardi FC. Effective Ablation of Pancreatic Cancer Cells in SCID Mice Using Systemic Adenoviral RIP-TK/GCV Gene Therapy. J Surg Res. 2007; 141:45-52.
    19. Ballian N, Brunicardi FC. Islet vasculature as a regulator of endocrine pancreas function. World J Surg. 2007; 31:705-14.
    20. Levy S, Zhou B, Ballian N, Li Z, Liu SH, Feanny M, Wang XP, Blanchard DK, Brunicardi FC. Cytotoxic gene therapy for human breast cancer in vitro. J Surg Res. 2006; 136:154-60.
    21. Ballian N, Brunicardi FC, Wang XP. Somatostatin and its receptors in the development of the endocrine pancreas. Pancreas. 2006; 33:1-12.
    22. Ballian N, Mantoudis E, Kaltsas GA. Pregnancy following ovarian drilling in a woman with polycystic ovary syndrome and nine previous first trimester miscarriages. Arch Gynecol Obstet. 2006; 273:384-6.

    Membership in Societies and Editorial Boards

    • American Board of Surgery
    • American College of Surgeons
    • Wisconsin Medical Board
    • Athens Medical Board
  • Research
    • Research Fellow, Pancreatic Physiology, Baylor College of Medicine, Houston. TX, USA, 2005-2006